Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2015-12-01 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTCEAU-LES-MINES (71300), Saone-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE LAGNEAU : revenue, balance sheet and financial ratios
SELARL PHARMACIE LAGNEAU is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTCEAU-LES-MINES (71300),
this company of category PME
shows in 2024 a net income positive of 50 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LAGNEAU (SIREN 814735874)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
50 242 €
47 710 €
165 444 €
283 626 €
47 359 €
33 639 €
58 983 €
85 474 €
112 538 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2024 erzielt SELARL PHARMACIE LAGNEAU ein positives Nettoergebnis von 50 k€. Entwicklung 2016-2024: 113 k€ -> 50 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
50 242 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 190%. Kritische Situation: Die Schulden übersteigen das Eigenkapital erheblich. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 27%. Das Gleichgewicht zwischen Eigenkapital und Schulden ist zufriedenstellend.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
189.726%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
26.967%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
337.333
179.786
141.035
108.699
841.143
407.24
304.611
244.073
189.726
Financial autonomy
18.804
31.623
38.072
43.805
9.626
17.315
21.517
24.622
26.967
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Verschuldungsgrad
189.732024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
Im Jahr 2024 liegt über dem Median der Branche das verschuldungsgrad von SELARL PHARMACIE LAGNEAU (189.73). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Finanzielle Autonomie
26.97%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Beobachten
Im Jahr 2024 liegt in den unteren 25% der Branche das finanzielle autonomie von SELARL PHARMACIE LAGNEAU (27.0%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Geringe Autonomie kann die Investitionsfähigkeit einschränken und die Verwundbarkeit erhöhen.
Liquidity ratios
Die Liquiditätsquote beträgt 84.62. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
189.196
320.305
434.574
410.928
248.546
193.707
193.803
132.66
84.617
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquiditätsquote
84.622024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Beobachten-30 pts over 3 years
Im Jahr 2024 liegt in den unteren 25% der Branche das liquiditätsquote von SELARL PHARMACIE LAGNEAU (84.62). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Positioning of SELARL PHARMACIE LAGNEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE LAGNEAU is estimated at
701 415 €
(range 488 454€ - 1 049 357€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
488k€701k€1049k€
701 415 €Range: 488 454€ - 1 049 357€
NAF 5 année 2024
Valuation method used
Net Income Multiple
50 242 €
×
14.0x
=701 415 €
Range: 488 455€ - 1 049 358€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LAGNEAU with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LAGNEAU
What is the revenue of SELARL PHARMACIE LAGNEAU ?
The revenue of SELARL PHARMACIE LAGNEAU is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE LAGNEAU profitable?
Yes, SELARL PHARMACIE LAGNEAU generated a net profit of 50 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE LAGNEAU ?
The headquarters of SELARL PHARMACIE LAGNEAU is located in MONTCEAU-LES-MINES (71300), in the department Saone-et-Loire.
Where to find the tax return of SELARL PHARMACIE LAGNEAU ?
The tax return of SELARL PHARMACIE LAGNEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LAGNEAU operate?
SELARL PHARMACIE LAGNEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart